{
    "id": 12802,
    "fullName": "RET Y806C",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "RET Y806C lies within the protein kinase domain of the Ret protein (UniProt.org). Y806C is predicted to lead to a gain of Ret protein function as indicated by transformation of cultured cells in one study (PMID:10679286), and has also been demonstrated to occur as a secondary resistance mutation in conjunction with other RET mutations (PMID: 19029224).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 8446,
                    "pubMedId": 19029224,
                    "title": "Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19029224"
                },
                {
                    "id": 11578,
                    "pubMedId": 10679286,
                    "title": "A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10679286"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5979,
        "geneSymbol": "RET",
        "terms": [
            "RET",
            "CDHF12",
            "CDHR16",
            "HSCR1",
            "MEN2A",
            "MEN2B",
            "MTC1",
            "PTC",
            "RET-ELE1"
        ]
    },
    "variant": "Y806C",
    "createDate": "10/05/2015",
    "updateDate": "10/17/2018",
    "referenceTranscriptCoordinates": {
        "id": 125442,
        "transcript": "NM_020975",
        "gDna": "chr10:g.43119555A>G",
        "cDna": "c.2417A>G",
        "protein": "p.Y806C",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3223,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Iclusig (ponatinib) inhibited phosphorylation of Ret in transformed human cells expressing RET Y806C in culture (PMID: 23526464).",
            "molecularProfile": {
                "id": 12957,
                "profileName": "RET Y806C"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 312,
                    "pubMedId": 23526464,
                    "title": "Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23526464"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10661,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed human cells co-expressing RET C634R and RET Y806C were resistant to treatment with Caprelsa (vandetanib) in culture (PMID: 19029224).",
            "molecularProfile": {
                "id": 27717,
                "profileName": "RET C634R RET Y806C"
            },
            "therapy": {
                "id": 953,
                "therapyName": "Vandetanib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 8446,
                    "pubMedId": 19029224,
                    "title": "Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19029224"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 13695,
            "approvalStatus": "Guideline",
            "evidenceType": "Risk Factor",
            "efficacyEvidence": "Compound germline RET V840M and Y806C mutations result in multiple endocrine neoplasia, type 2B (MEN 2B), which is associated with high risk of developing thyroid medullary carcinoma (NCCN.org).",
            "molecularProfile": {
                "id": 29379,
                "profileName": "RET V804M RET Y806C"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 3973,
                "name": "thyroid gland medullary carcinoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 12957,
            "profileName": "RET Y806C",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27717,
            "profileName": "RET C634R RET Y806C",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 29379,
            "profileName": "RET V804M RET Y806C",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 125442,
            "transcript": "NM_020975",
            "gDna": "chr10:g.43119555A>G",
            "cDna": "c.2417A>G",
            "protein": "p.Y806C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 125443,
            "transcript": "NM_020630",
            "gDna": "chr10:g.43119555A>G",
            "cDna": "c.2417A>G",
            "protein": "p.Y806C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}